L-pampo

N/A

Report date: 2025/03/20 15:08:00
NME

Base Information

Drug NameL-pampo
Drug Alias NameTLR 1/2/3 agonist (CHA Vaccine Institute)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 1 agonistsToll like receptor 2 agonistsToll like receptor 3 agonists
TargetsToll like receptor 1Toll like receptor 3Toll like receptor 2
Therapy Area/IndicationsColorectal NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCha Vaccine Institute Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCha Vaccine Institute Co Ltd
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A